Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Work at the Cambodia Oxford Medical Research Unit (COMRU) and Angkor Hospital for Children (AHC) has highlighted the importance of melioidosis, infection by the soil-dwelling bacterium Burkholderia pseudomallei, as a cause of severe illness in Cambodian children.

Work at the Cambodia Oxford Medical Research Unit (COMRU) and Angkor Hospital for Children (AHC) has highlighted the importance of melioidosis, infection by the soil-dwelling bacterium Burkholderia pseudomallei, as a cause of severe illness in Cambodian children (P Turner et al and Pagnarith et al).

In October 2017, COMRU will participate in the 2nd Cambodia National Melioidosis workshop, a three day event to improve awareness of Burkholderia pseudomallei infection amongst Cambodian clinicians and laboratory technicians. COMRU’s Miliya Thyl and Soeng Sona will both give presentations at the meeting, alongside director Paul Turner.

To support the workshop’s laboratory sessions, COMRU commissioned a short film in English [above] and Khmer to demonstrate laboratory identification of B. pseudomallei. The video was shot at Angkor Hospital for Children and the microbiology laboratory of the Cambodia Oxford Medical Research Unit. We are very grateful to MORU’s Prof Phaikyeong Cheah and the Wellcome Trust for provision of public engagement funding to support the making of the film.

Cambodia Oxford Medical Research Unit (COMRU)

The Cambodia Oxford Medical Research Unit (COMRU) was established in 2007 as a collaboration between the Angkor Hospital for Children and MORU. The first step in this collaboration was to equip the Angkor Hospital with a microbiological laboratory, and to train the Hospital's technical staff. COMRU are now using this facility to prospectively define the causes of febrile illness and establish susceptibility patterns of common culturable bacterial pathogens. These data will also allow researchers to identify causes of sepsis and sepsis-related death, and will improve diagnosis, treatment and management of paediatric infections in Cambodia. The Mahidol Oxford Tropical Medicine Research Unit (MORU) develops effective and practical means of diagnosing and treating malaria and other neglected diseases such as melioidosis, typhus, TB and leptospirosis.

Mahidol Oxford Tropical Medicine Research Unit (MORU)

MORU was established in 1979 as a research collaboration between Mahidol University (Thailand), Oxford University (UK) and the UK’s Wellcome Trust. MORU’s main office and laboratories are located within the Faculty of Tropical Medicine at Mahidol University in Bangkok, Thailand, with MORU study sites and collaborations across Thailand, Asia and Africa. MORU is generously supported with significant funding from the Wellcome Trust, our major funding partner. We also receive funding from other trusts and foundations, governments, and multi-lateral donors.

Angkor Hospital for Children (AHC)

Renowned Japanese photographer Kenro Izu first visited Cambodia in 1993 to photograph the magnificent Angkor Temples. Cambodia was struggling to emerge from the brutal Khmer Rouge regime, and Kenro was deeply touched by the resilient children he met during his trip. Kenro realized he could not leave Cambodia without doing something for these impoverished children he had seen and captured from behind the lens. He founded a non-profit organization called Friends Without a Border (FWAB) and with the help of the international art community, health care professionals and more than 6,000 supporters from around the world, Angkor Hospital for Children opened its gates in 1999. Today, Claudia Turner is the CEO of the hospital and is an Oxford University Principal Investigator.

Paul Turner (COMRU Director)

Paul Turner is a clinical microbiologist based at the Angkor Hospital for Children in Siem Reap, Cambodia. He is director of the Cambodia-Oxford Medical Research Unit (COMRU).

His research interests include:

  • Antimicrobial resistance surveillance and control;
  • Paediatric healthcare associated infections;
  • Pneumococcal colonisation and disease and the impact of pneumococcal vaccines.

Similar stories

Evidence supports WHO recommendation for primaquine combined with ACTs to block Plasmodium falciparum transmission

MORU Bangkok Publication Research

Evidence from a new study, initiated by the Primaquine Roll Out Group and conducted at WWARN, supports the World Health Organization (WHO) recommendation for use of 0.25mg/kg dose of primaquine (PQ) combined with artemisinin-based combination therapies (ACT) to block Plasmodium falciparum transmission.

Check-list recommended to improve reporting of microscopy methods and results in malaria studies

MORU Bangkok Publication Research

A study to explore the variations of how microscopy methods are reported in published malaria studies has recommended standardised procedures should be implemented for methodological consistency and comparability of clinical trial outcomes.

The COVID-19 vaccine: do we know enough to end the pandemic?

MORU Bangkok Research

Blog by Rima Shretta. Preliminary efficacy results from three vaccine candidates currently in Phase 3 trials have shown an efficacy of more than 90% against the development of symptomatic COVID-19. While these results are promising, all vaccines are in relatively early stages of testing. A comprehensive and transparent roadmap is urgently needed, to determine how limited doses of the first vaccines to be licensed will be distributed, together with which groups will initially be prioritized.

New study on the risk of Plasmodium vivax parasitaemia after Plasmodium falciparum malaria

MORU Bangkok Publication Research

A new study quantifying the high risk of Plasmodium vivax parasitaemia after treatment of Plasmodium falciparum malaria aims to identify populations in which a policy of universal radical cure, combining artemisinin-based combination therapy with a hypnozoitocidal antimalarial drug, would be most beneficial.

Oxford Global Research

COMRU MOCRU MORU Bangkok Research SMRU

Oxford is world-famous for research excellence and home to some of the most talented people from across the globe. To showcase our global research, the University launched a Global Research Map, highlighting areas of research we are conducting overseas.

Parenting for lifelong health for young children, project led by MORU Bioethics & Engagement Amalee McCoy

MORU Bangkok Public Engagement Video

The University of Oxford, MORU, the University of Cape Town, the Thai Ministry of Public Health, and UNICEF Thailand worked together to promote lifelong health and well-being, and prevent violence against children. Led by Amalee McCoy from MORU Department of Bioethics & Engagement, this project involved the cultural adaptation and testing of an evidence-based parenting intervention for low-income families with children aged 2-9 living in Udon Thani, Thailand.